Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area - PubMed (original) (raw)

Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area

Satoru Ozaki et al. J Neurochem. 2002 Sep.

Free article

Abstract

The present study was designed to investigate the rewarding effect, G-protein activation and dopamine (DA) release following partial sciatic nerve ligation in the rat. Here we show for the first time that morphine failed to produce a place preference in rats with nerve injury. Various studies provide arguments to support that the mesolimbic dopaminergic system, which projects from the ventral tegmental area (VTA) to the nucleus accumbens (N.Acc), is critical of the motivational effects of opioids. In the present study, there were no significant differences between sham-operated and sciatic nerve-ligated rats in the increases in guanosine-5'-o-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding to membranes of the N.Acc stimulated by either DA, the D1 receptor agonist SKF81297, the D2 receptor agonist N-propylnoraporphine or the D3 receptor agonist 7-hydroxy-2-dipropylaminotetralin (7-OH DPAT). In contrast, the increases in [35S]GTPgammaS binding to membranes of the VTA induced by either morphine or a selective micro -opioid receptor agonist [d-Ala2, NMePhe4, Gly(ol)5]enkephalin were significantly attenuated in nerve-ligated rats as compared with sham- operated rats. Furthermore, the enhancement of DA release in the N.Acc stimulated by morphine was significantly suppressed by sciatic nerve ligation. These findings suggest that attenuation of the morphine-induced place preference under neuropathic pain may result from a decrease in the morphine-induced DA release in the N.Acc with reduction in the mu-opioid receptor-mediated G-protein activation in the VTA.

PubMed Disclaimer

Cited by

The response to rapid infusion of fentanyl in the human brain measured using pulsed arterial spin labelling.
Zelaya FO, Zois E, Muller-Pollard C, Lythgoe DJ, Lee S, Andrews C, Smart T, Conrod P, Vennart W, Williams SC, Mehta MA, Reed LJ. Zelaya FO, et al. MAGMA. 2012 Apr;25(2):163-75. doi: 10.1007/s10334-011-0293-4. Epub 2011 Nov 24. MAGMA. 2012. PMID: 22113518
[Chronic pain : Perception, reward and neural processing].
Becker S, Diers M. Becker S, et al. Schmerz. 2016 Oct;30(5):395-406. doi: 10.1007/s00482-016-0149-y. Schmerz. 2016. PMID: 27576865 Review. German.
Chronic pain alters drug self-administration: implications for addiction and pain mechanisms.
Martin TJ, Ewan E. Martin TJ, et al. Exp Clin Psychopharmacol. 2008 Oct;16(5):357-66. doi: 10.1037/a0013597. Exp Clin Psychopharmacol. 2008. PMID: 18837632 Free PMC article. Review.
An ethogram analysis of cutaneous thermal pain sensitivity and oxycodone reward-related behaviors in rats.
Brice-Tutt AC, Montgomery DS, Kramer CM, Novotny PM, Malphurs WL, Sharma A, Caudle RM, Bruijnzeel AW, Setlow B, Neubert JK, Murphy NP. Brice-Tutt AC, et al. Sci Rep. 2023 Jun 28;13(1):10482. doi: 10.1038/s41598-023-36729-6. Sci Rep. 2023. PMID: 37380739 Free PMC article.
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.
Koob GF. Koob GF. Pharmacol Rev. 2021 Jan;73(1):163-201. doi: 10.1124/pharmrev.120.000083. Pharmacol Rev. 2021. PMID: 33318153 Free PMC article. Review.

Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area - PubMed (original) (raw)